Combating ovarian hyperstimulation syndrome in polycystic ovary syndrome: Lessons from clinical case reports and research

Conflict of interest statement

The authors declare no conflicts of interest to disclose.

Funding

The study receives no extramural funding.

Authors’ contributions

The main frame of the Letter was written by Dr Pallav Sengupta and Dr Sulagna Dutta. All the authors have conducted editing, framing, reviewing and referencing of the manuscript. All the authors have read and agreed to the published version of the manuscript.

Publisher’s Note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Khalife D, Ghunaim S, El Taha L, Odeh O, Habr N, Awwad J. Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze-all strategy: A case report and review of the literature. Asian Pac J Reprod 2022; 11(6): 292-298.

[2] Hassan MF, Abdul-Kadim H, Edan BJ, Dutta S, Sengupta P. Embryo quality and intracytoplasmic sperm injection (ICSI) outcome in Iraqi women with polycystic ovary syndrome (PCOS): A cohort prospective study. Biomed Pharmacol J 2023; 16(2): 863-870.

[3] Bhattacharya K, Saha I, Sen D, Bose C, Chaudhuri GR, Dutta S, et al. Role of anti-Mullerian hormone in polycystic ovary syndrome. Middle East Fertil Soc J 2022; 27(1): 32.

[4] Bhargavi S, Swain S, Mishra A, Pradhan AK. In vitro fertilization: Facts in medical sciences. Asian Pac J Reprod 2018; 7(4): 145-150.

[5] Eftekhar M, Agha-Rahimi A, Khalili MA, Omidi M. Missed estradiol determination resulting in oocyte retrieval and embryo development following controlled ovarian hyperstimulation at early pregnancy: Case report. Asian Pac J Reprod 2018; 7(3): 143-144.